GT Biopharma, Inc. - Common Stock (NQ:GTBP)

9.000 -2.630 (-22.61%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 15, 2026 Add to My Watchlist

Price and Volume

Volume	334,272
Open	10.48
Bid (Size)	8.550 (100)
Ask (Size)	9.110 (1,000)
Prev. Close	11.63
Today's Range	8.130 - 10.48
52wk Range	0.2221 - 11.98
Shares Outstanding	31,553,892
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

Today 10:30 EDT

Via Chartmill

Top movers in Friday's session ↗

September 11, 2026

Via Chartmill

Performance

YTD	+1001.5%	+1001.5%
1 Month	+3057.9%	+3057.9%
3 Month	+1820.2%	+1820.2%
6 Month	+2018.1%	+2018.1%
1 Year	+1024.4%	+1024.4%

More News

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

September 11, 2026

Via Chartmill

Stay updated with the stocks that are on the move in today's after-hours session. ↗

September 04, 2026

Via Chartmill

After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell

June 12, 2026

From Equity Insider

Via GlobeNewswire

Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet

June 08, 2026

From Biotech Insider

Via GlobeNewswire

These stocks are moving in today's session ↗

May 14, 2026

Via Chartmill

What's going on in today's session ↗

May 14, 2026

Via Chartmill

"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies

May 14, 2026

From World Street Intelligence

Via GlobeNewswire

Which stocks are gapping on Thursday? ↗

May 14, 2026

Via Chartmill

A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology

May 14, 2026

From USA News Group

Via GlobeNewswire

Solid Tumor Treatment Race Heats Up as Multi-Billion-Dollar Oncology Market Enters High-Growth Phase

May 14, 2026

Via FinancialNewsMedia

Discover the top movers in Thursday's pre-market session. ↗

May 14, 2026

Via Chartmill

Replays from RedChip's Biotech Investor Conference Now Available

April 20, 2026

Via ACCESS Newswire

RedChip's April 16 Virtual Investor Conference to Highlight Companies Driving the Next Wave of Biotech Innovation

April 10, 2026

Via ACCESS Newswire

Monday's session: top gainers and losers ↗

February 02, 2026

Via Chartmill

THE SCARCITY DOCTRINE: 5 Assets Securing the 2026 Material Cycle

January 16, 2026

From Equity Insider

Via GlobeNewswire

Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge

December 24, 2025

From Equity Insider

Via GlobeNewswire

THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis

December 15, 2025

From USA News Group

Via GlobeNewswire

THE REALITY CHECK: 5 Assets Delivering Proof in a Speculative Market

December 11, 2025

From Equity Insider

Via GlobeNewswire

GT Biopharma, Inc. (NASDAQ:GTBP) Offers Near-Term Catalyst Opportunity with Advancing Phase 1 Trials

November 19, 2025

Via ACCESS Newswire

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

November 17, 2025

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 17, 2025

Via Benzinga

The market is filled with gapping stocks in Monday's session. ↗

November 17, 2025

Via Chartmill

These stocks are moving in today's pre-market session ↗

November 17, 2025

Via Chartmill

Frequently Asked Questions

Is GT Biopharma, Inc. - Common Stock publicly traded?

Yes, GT Biopharma, Inc. - Common Stock is publicly traded.

What exchange does GT Biopharma, Inc. - Common Stock trade on?

GT Biopharma, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for GT Biopharma, Inc. - Common Stock?

The ticker symbol for GT Biopharma, Inc. - Common Stock is GTBP on the Nasdaq Stock Market

What is the current price of GT Biopharma, Inc. - Common Stock?

The current price of GT Biopharma, Inc. - Common Stock is 9.000

When was GT Biopharma, Inc. - Common Stock last traded?

The last trade of GT Biopharma, Inc. - Common Stock was at 09/15/26 04:00 PM ET

What is the market capitalization of GT Biopharma, Inc. - Common Stock?

The market capitalization of GT Biopharma, Inc. - Common Stock is 283.99M

How many shares of GT Biopharma, Inc. - Common Stock are outstanding?

GT Biopharma, Inc. - Common Stock has 284M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.